The ZNF217 biomarker predicts low-and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers

Pascale A. Cohen, Olivier Loudig, Christina Liu, Joseph Albanese, Susan A. Fineberg

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article number524
JournalFrontiers in Pharmacology
Volume10
Issue numberMAY
DOIs
StatePublished - Jan 1 2019

Fingerprint

Biomarkers
Breast Neoplasms
Recurrence

Keywords

  • Biomarker
  • Breast cancer
  • Estrogen-receptor positive
  • Expression
  • Oncotype DX®
  • ZNF217

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The ZNF217 biomarker predicts low-and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers. / Cohen, Pascale A.; Loudig, Olivier; Liu, Christina; Albanese, Joseph; Fineberg, Susan A.

In: Frontiers in Pharmacology, Vol. 10, No. MAY, 524, 01.01.2019.

Research output: Contribution to journalArticle

@article{7cdede08e6e443808c7696162542a018,
title = "The ZNF217 biomarker predicts low-and high-risk oncotype DX{\circledR} recurrence score in ER-positive invasive breast cancers",
keywords = "Biomarker, Breast cancer, Estrogen-receptor positive, Expression, Oncotype DX{\circledR}, ZNF217",
author = "Cohen, {Pascale A.} and Olivier Loudig and Christina Liu and Joseph Albanese and Fineberg, {Susan A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fphar.2019.00524",
language = "English (US)",
volume = "10",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - The ZNF217 biomarker predicts low-and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers

AU - Cohen, Pascale A.

AU - Loudig, Olivier

AU - Liu, Christina

AU - Albanese, Joseph

AU - Fineberg, Susan A.

PY - 2019/1/1

Y1 - 2019/1/1

KW - Biomarker

KW - Breast cancer

KW - Estrogen-receptor positive

KW - Expression

KW - Oncotype DX®

KW - ZNF217

UR - http://www.scopus.com/inward/record.url?scp=85068864244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068864244&partnerID=8YFLogxK

U2 - 10.3389/fphar.2019.00524

DO - 10.3389/fphar.2019.00524

M3 - Article

VL - 10

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - MAY

M1 - 524

ER -